文献速递胸部肿瘤放疗放疗物理与技术

肺癌放疗急性食管炎的剂量学预测因素:全州范围观察性研究结果

Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study.
PubMed 文献 · Pract Radiat Oncol · 2017-07-19

该研究基于密歇根放射肿瘤学质量联盟前瞻性收集的533例II-III期非小细胞肺癌根治性放疗患者,分析剂量体积直方图参数与急性食管炎的关系。多变量模型显示gEUD是≥2级和≥3级食管炎的最显著预测因子,其次为D2cc;将≥3级食管炎风险控制在5%时,gEUD和D2cc的阈值分别为59.3 Gy和68 Gy。

要点

  • gEUD是预测≥2级和≥3级急性食管炎的最显著剂量学指标
  • 当gEUD不在模型时,D2cc是≥3级食管炎的最强预测因子
  • 将≥3级食管炎风险控制在5%时,gEUD阈值59.3 Gy、D2cc阈值68 Gy

核心结论

  • gEUD和D2cc而非平均剂量是重度食管炎的最具预测价值的剂量指标。
  • 将≥3级食管炎估计风险控制在5%以下时,gEUD和D2cc的阈值分别为59.3 Gy和68 Gy。

研究设计与样本

  • 前瞻性收集的密歇根放射肿瘤学质量联盟数据,纳入533例接受根治性放疗的II-III期非小细胞肺癌患者。
  • 分析剂量体积直方图参数(V10至V60、D2cc、平均剂量、gEUD),用逻辑回归和ROC曲线评估预测能力。

主要发现

  • 533例患者中437例(81.9%)发生任意级别食管炎。
  • ≥2级食管炎的单因素显著变量包括同步化疗、V20、V30、V40、V50、V60、平均剂量、D2cc和gEUD。
  • ≥3级食管炎的预测变量为V30、V40、V50、V60、平均剂量、D2cc和gEUD。
  • 多变量模型中gEUD是≥2级和≥3级食管炎的最显著预测因子;排除gEUD后D2cc是≥3级食管炎的最强预测变量。

关键数值与推荐

  • 将≥3级食管炎估计风险控制在5%时,gEUD阈值为59.3 Gy,D2cc阈值为68 Gy。

临床怎么用

  • 在肺癌根治性放疗计划评估中,可优先关注gEUD和D2cc以预测重度急性食管炎风险。
  • 可参考gEUD 59.3 Gy和D2cc 68 Gy的阈值,将≥3级食管炎估计风险控制在5%以下。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study is to identify dosimetric variables that best predict for acute esophagitis in patients treated for locally advanced non-small cell lung cancer in a prospectively accrued statewide consortium. METHODS AND MATERIALS: Patients receiving definitive radiation therapy for stage II-III non-small cell lung cancer within the Michigan Radiation Oncology Quality Consortium were included in the analysis. Dose-volume histogram data were analyzed to determine absolute volumes (cc) receiving doses from 10 to 60 Gy (V10, V20, V30, V40, V50, and V60), as well as maximum dose to 2 cc (D2cc), mean dose (MD), and generalized equivalent uniform dose (gEUD). Logistic regression models were used to characterize the risk of toxicity as a function of dose and other covariates. The ability of each variable to predict esophagitis, individually or in a multivariate model, was quantified by receiver operating characteristic analysis. RESULTS: There were 533 patients who met study criteria and were included; 437 (81.9%) developed any grade of esophagitis. Significant variables on univariate analysis for grade ≥2 esophagitis were concurrent chemotherapy, V20, V30, V40, V50, V60, MD, D2cc, and gEUD. For grade ≥3 esophagitis, the predictive variables were: V30, V40, V50, V60, MD, D2cc, and gEUD. In multivariable modeling, gEUD was the most significant predictor of both grade ≥2 and grade ≥3 esophagitis. When gEUD was excluded from the model, D2cc was selected as the most predictive variable for grade ≥3 esophagitis. For an estimated risk of grade ≥3 esophagitis of 5%, the threshold values for gEUD and D2cc were 59.3 Gy and 68 Gy, respectively. CONCLUSIONS: In this study, we report the novel finding that gEUD and D2cc, rather than MD, were the most predictive dose metrics for severe esophagitis. To limit the estimated risk of grade ≥3 esophagitis to <5%, thresholds of 59.3 Gy and 68 Gy were identified for gEUD and D2cc, respectively.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Paximadis P, Schipper M, Matuszak M, et al. Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study. Pract Radiat Oncol. 2017. PMID: 28919249. doi:10.1016/j.prro.2017.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。